Robert I. Parker

2.8k total citations · 1 hit paper
42 papers, 1.6k citations indexed

About

Robert I. Parker is a scholar working on Hematology, Biochemistry and Immunology. According to data from OpenAlex, Robert I. Parker has authored 42 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 9 papers in Biochemistry and 8 papers in Immunology. Recurrent topics in Robert I. Parker's work include Platelet Disorders and Treatments (11 papers), Blood transfusion and management (9 papers) and Trauma, Hemostasis, Coagulopathy, Resuscitation (6 papers). Robert I. Parker is often cited by papers focused on Platelet Disorders and Treatments (11 papers), Blood transfusion and management (9 papers) and Trauma, Hemostasis, Coagulopathy, Resuscitation (6 papers). Robert I. Parker collaborates with scholars based in United States, Canada and Australia. Robert I. Parker's co-authors include Samuel H. Doppelt, Suvimol Hill, Henry J. Mankin, Gary J. Murray, Norman W. Barton, Adrian M. Di Bisceglie, Charles E. Argoff, James M. Dambrosia, Roscoe O. Brady and Raji P. Grewal and has published in prestigious journals such as New England Journal of Medicine, PEDIATRICS and The American Journal of Medicine.

In The Last Decade

Robert I. Parker

39 papers receiving 1.6k citations

Hit Papers

Replacement Therapy for Inherited Enzyme Deficiency — Mac... 1991 2026 2002 2014 1991 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Replacement Therapy for Inherited Enzyme Deficiency — Macrophage-Targeted Glucocerebrosidase for Gaucher's Disease
    1991 981 citations Norman W. Barton, Adrian M. Di Bisceglie et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert I. Parker United States 16 988 478 434 375 351 42 1.6k
Sharda G. Sabnis United States 17 1.5k 1.5× 727 1.5× 357 0.8× 389 1.0× 369 1.1× 32 2.3k
L. Astudillo France 17 509 0.5× 282 0.6× 245 0.6× 342 0.9× 134 0.4× 69 1.2k
Sandrine Laradi France 19 290 0.3× 183 0.4× 39 0.1× 187 0.5× 62 0.2× 77 1.3k
C. G. Groth Sweden 22 238 0.2× 261 0.5× 158 0.4× 553 1.5× 46 0.1× 78 1.8k
Jacqueline Madden United Kingdom 14 438 0.4× 63 0.1× 54 0.1× 261 0.7× 17 0.0× 21 1.1k
Hirahito Endo Japan 24 133 0.1× 257 0.5× 34 0.1× 407 1.1× 27 0.1× 59 1.6k
Arno Fuchshuber Germany 21 212 0.2× 95 0.2× 122 0.3× 1.1k 3.0× 18 0.1× 37 2.5k
Keiko Maeda Japan 19 255 0.3× 145 0.3× 38 0.1× 252 0.7× 20 0.1× 40 1.6k
Masahide Mori Japan 22 105 0.1× 154 0.3× 56 0.1× 283 0.8× 25 0.1× 110 1.4k
Yoshinori Tanino Japan 18 203 0.2× 163 0.3× 143 0.3× 158 0.4× 16 0.0× 65 966

Countries citing papers authored by Robert I. Parker

Since Specialization
Citations

This map shows the geographic impact of Robert I. Parker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert I. Parker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert I. Parker more than expected).

Fields of papers citing papers by Robert I. Parker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert I. Parker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert I. Parker. The network helps show where Robert I. Parker may publish in the future.

Co-authorship network of co-authors of Robert I. Parker

This figure shows the co-authorship network connecting the top 25 collaborators of Robert I. Parker. A scholar is included among the top collaborators of Robert I. Parker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert I. Parker. Robert I. Parker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Nellis, Marianne E., Kenneth E. Remy, Jacques Lacroix, et al.. (2022). Research Priorities for Plasma and Platelet Transfusion Strategies in Critically Ill Children: From the Transfusion and Anemia EXpertise Initiative–Control/Avoidance of Bleeding. Pediatric Critical Care Medicine. 23(Supplement 1 1S). e63–e73. 10 indexed citations
3.
4.
5.
Parker, Robert I., et al.. (2021). Hemostatic Testing in Critically Ill Infants and Children. Frontiers in Pediatrics. 8. 606643–606643. 3 indexed citations
6.
Sloan, Steven R. & Robert I. Parker. (2016). Current Status of Platelet Transfusion in Pediatric Patients. Transfusion Medicine Reviews. 30(4). 230–234. 8 indexed citations
7.
Parker, Robert I., et al.. (2014). Diagnostic Outcome of Preoperative Coagulation Testing in Children. Pediatric Hematology and Oncology. 31(5). 458–466. 14 indexed citations
8.
Parker, Robert I.. (2013). Coagulopathies in the PICU. Critical Care Clinics. 29(2). 319–333. 13 indexed citations
9.
Parker, Robert I.. (2012). Etiology and Significance of Thrombocytopenia in Critically Ill Patients. Critical Care Clinics. 28(3). 399–411. 26 indexed citations
10.
Parker, Robert I.. (2010). Thrombosis in the pediatric population. Critical Care Medicine. 38(2 Suppl). S71–S75. 23 indexed citations
11.
Garnett, Sarah P., Louise A. Baur, Manny Noakes, et al.. (2010). Researching Effective Strategies to Improve Insulin Sensitivity in Children and Teenagers - RESIST. BMC Public Health. 10. 13 indexed citations
12.
Mehta, Parth S. & Robert I. Parker. (2010). Imbalance of Plasminogen Activator Inhibitor Type-1 (PAI-1) and Tissue Plasminogen Activator (t-PA) Activity in Patients With Noonan Syndrome. Journal of Pediatric Hematology/Oncology. 32(7). 532–536. 4 indexed citations
13.
Parker, Robert I.. (2010). Thrombosis in the intensive care unit: Protein C and a whole lot more!. Critical Care Medicine. 38(2 Suppl). S1–S2. 2 indexed citations
14.
Parker, Robert I., et al.. (2002). Randomized Trial of High-Dose Methylprednisolone Versus Intravenous Immunoglobulin for the Treatment of Acute Idiopathic Thrombocytopenic Purpura in Children. Journal of Pediatric Hematology/Oncology. 24(7). 540–544. 35 indexed citations
15.
Parker, Robert I.. (2000). HEMATOLOGIC ASPECTS OF SYSTEMIC MASTOCYTOSIS. Hematology/Oncology Clinics of North America. 14(3). 557–568. 35 indexed citations
16.
Felix, Carolyn A., Matthew R. Hosler, Diana J. Slater, et al.. (1998). MLL Genomic Breakpoint Distribution Within the Breakpoint Cluster Region in De Novo Leukemia in Children. Journal of Pediatric Hematology/Oncology. 20(4). 299–308. 35 indexed citations
17.
Parker, Robert I.. (1997). ETIOLOGY AND TREATMENT OF ACQUIRED COAGULOPATHIES IN THE CRITICALLY ILL ADULT AND CHILD. Critical Care Clinics. 13(3). 591–609. 15 indexed citations
18.
Barton, Norman W., Roscoe O. Brady, Samuel H. Doppelt, et al.. (1992). Dose-dependent responses to macrophage-targeted glucocerebrosidase in a child with Gaucher disease. The Journal of Pediatrics. 120(2). 277–280. 47 indexed citations
19.
Parker, Robert I.. (1991). Hematologic Aspects of Mastocytosis: I: Bone Marrow Pathology in Adult and Pediatric Systemic Mast Cell Disease. Journal of Investigative Dermatology. 96(3). S47–S51. 38 indexed citations
20.
Travis, William D., George E. Davis, Maria Tsokos, et al.. (1989). Multifocal Verruciform Xanthoma of the Upper Aerodigestive Tract in a Child with a Systemic Lipid Storage Disease. The American Journal of Surgical Pathology. 13(4). 309–316. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sharda G. Sabnis Breakdown of academic impact, for papers by L. Astudillo Breakdown of academic impact, for papers by Sandrine Laradi Breakdown of academic impact, for papers by C. G. Groth Breakdown of academic impact, for papers by Jacqueline Madden Breakdown of academic impact, for papers by Hirahito Endo Breakdown of academic impact, for papers by Arno Fuchshuber Breakdown of academic impact, for papers by Keiko Maeda Breakdown of academic impact, for papers by Masahide Mori Breakdown of academic impact, for papers by Yoshinori Tanino
Rankless by CCL
2026